USA Ifijiṣẹ Ile, Ifijiṣẹ Ile Gẹẹsi ti Ọja, Ifijiṣẹ Ilẹ Ti Ilu Europe

11α-Hydroxy canrenone lulú (192569-17-8)

Rating:
2.75 jade ti 5 da lori 4 alabara-wonsi
SKU: 192569-17-8. Ẹka:

AASraw wa pẹlu iṣelọpọ ati agbara iṣelọpọ lati gram si aṣẹ pupọ ti 11α-Hydroxy canrenone Powder (192569-17-8), labẹ ilana CGMP ati eto iṣakoso didara didara.

Ọja Apejuwe

11α-Hydroxy canrenone Powder (192569-17-8) fidio


11α-Hydroxy canrenone lulú (192569-17-8) Specification:

Ẹya Kẹmika: ọja orukọ:11α-Hydroxy canrenone
Raw 11α-Hydroxy canrenone lulú (192569-17-8) hplc≥98% | AASraw CAS No.: 192569-17-8
molikula agbekalẹ: C22H28O4
molikula iwuwo: 356.46
Synonyms: 11-alpha-Hydroxycarvenone
Ibi: Gbẹ, ṣokunkun · ati ni 0 - 4 C fun igba kukuru (awọn ọjọ si awọn ọsẹ) tabi -20 C fun igba pipẹ (awọn oṣu si ọdun).
Awọn iwe aṣẹ (COA & HPLC ati bẹbẹ lọ): wa

11α-Hydroxy canrenone lulú (192569-17-8) Dorukọ:

11α-Hydroxy canrenone ṣiṣẹ kanna bi Canrenone jẹ antagonist aldosterone pẹlu iṣẹ diuretic potasiomu. Canrenone pataki antagonizes aldosterone ni olugba mineralocorticoid ninu awọn kidinrin, nitorinaa npo iṣuu soda ati didi iyọkuro potasẹ.Canrenone jẹ irohin agbara diẹ bi alafaramo antimineralocorticoid si spironolactone, ṣugbọn ni agbara pupọ ati pe o munadoko bi antiandrogen.11α-ọlọla sitẹriọdu ati ti iṣelọpọ ti progesterone.It jẹ antiandrogen ti ko lagbara, ati pe ko ni aibikita ati androgenic, estrogenic, ati iṣẹ ṣiṣe progestogenic

Reference:

  • Jürg Müller (6 Oṣu kejila ọdun 2012). Ilana Aldosterone Biosynthesis: Ti ẹkọ-iṣe ati imọ-ara ile-iwosan. Orisun omi Imọ-jinlẹ & Media. Oju ewe 164-. ISBN 978-3-642-83120-1.
  • Ford, Donald H. (1954). “AGBARA TI 11α-HYDROXYPROGESTERONE LATI IBI Iṣeduro TI NIPA TI A NIPA TI RẸ NI ỌJỌ ỌJỌ ỌJỌ RẸ *”. Iwe akosile ti Clinical Endocrinology & Ti iṣelọpọ. 14 (10): 1268–1270. doi: 10.1210 / jcem-14-10-1268. ISSN 0021-972X.
  • Souness GW, Latif SA, Laurenzo JL, Morris DJ (1995). “11 alfa- ati 11 beta-hydroxyprogesterone, awọn idiwọ agbara ti 11 beta-hydroxysteroid dehydrogenase (isoforms 1 ati 2), confer samisi iṣẹ mineralocorticoid lori corticosterone ninu eku ADX”. Endocrinology. 136 (4): 1809-12.

IKILO ATI IDAGBASOKE:

Ohun elo yii ni a Ta Fun Lilo Iwadi nikan. Awọn ofin Tita Waye. Kii ṣe fun Lilo Ọmọ eniyan, tabi Iṣoogun, Ile-iwosan, tabi Awọn lilo Ile.


pẹlu awọn

HNMR

10161-35-8 Trenbolone adanthate HNMR

ilana

Trenbolone enanthate Igbesi Pupa Lulu:

Lati wa Awọn Aṣoju Onibara (CSR) fun alaye, fun itọkasi rẹ.

Awọn itọkasi & awọn itọkasi ọja

Gbogbo Awọn Ohun Nipa Trenbolone Enanthate Powder

Bawo ni lati lo Trenbololone ohunelo lati ṣe adalu Trenbolone Enanthate Powder 2019

Itọsọna Gbẹhin: Bi o ṣe le lo Trenbololone ohunelo lati Illa Trenbolone Enanthate Foda sinu epo [2019]

To jo:

William Llewellyn, Ẹjẹ Ounjẹ Oro, Anabolics, 491 Pages - 499, 618, 724, 2011.

Kickman, AT, Pharmacology of Steroids Anabolic, British Journal of Pharmacology, PMC 2439524, Online, 2018.

Wilson, VS, Lambright, C., Ostby, J., Gray Jr, LE, In Vitro ati Ni Vivo Effects ti 17beta-Trenbolone: ​​kan Feedlot Effluent Contaminant, Toxicological Sciences, 2002.

Yarrow, JF, McCoy, SC, Borst, SE, Iyatọ Tiiṣe ati Awọn isẹ Awọn isẹgun Trenbolone: ​​Agbara alailẹgbẹ Anabolic pẹlu Iṣẹ Atẹyin Androgenic ati Estrogenic, Yiyan ti PubMed, Online, 2010.

Ojasoo, Raynaud., Awọn oniroyin sitẹriọdu ọtọtọ fun Awọn Iwadi gbigba, Iwadi Iwadi, 1978.